A federal appeals court in Washington, D.C. upheld the Pentagon's decision to blacklist Anthropic, an AI company, citing national security risks. The court rejected Anthropic's claims that the designation was arbitrary and unconstitutional. This ruling supports the Department of Defense's concerns about integrating Anthropic's AI system, Claude, into its information systems. The decision marks a significant setback for Anthropic in its legal battle with the Trump administration.
The U.S. appeals court decision on Anthropic comes as a backdrop to the Technology sector's mixed performance on Pluang. For readers following this sector, here is Pluang's market snapshot as of Sep 25, 2026 20:31 WIB: out of 150 priced Technology-sector US stocks, 75 rose and 69 fell. Notable movers include Zscaler Inc (ZS) down 4.67% with 97% sell order activity, Arm Holdings plc (ARM) up 4.58% with 61% sell orders, and Fastly Inc (FSLY) up 3.56% with 62% buy orders.
Ivanhoe Electric's Santa Cruz Copper Mining Project in Arizona has strong economic potential, according to a recent Preliminary Feasibility Study. The project requires $1.43 billion in initial capital and expects low operating costs of $1.47 per poun...
Westlake, a global chemical and building materials company, has a revised analyst price target indicating a 46.27% potential upside from its current stock price. Institutional investors like Bank of America and others are increasing their holdings, r...
PayPal's stock rose following its announcement of a new strategic partnership with Meta Platforms, integrating AI-powered shopping across its merchant network. Deutsche Bank increased its price target for PayPal to $55 from $50, signaling potential u...
DTE Energy has secured major hyperscale data center agreements with Oracle and Alphabet, positioning it for significant growth amid rising US electricity demand driven by AI. Despite a nearly 10% stock decline in the past month, the company’s strong ...
Humana's stock surged 7% following Barclays' upgrade from Neutral to Overweight and a raised price target of $515, signaling increased analyst confidence. This move stands out as the broader healthcare sector and competitors like UnitedHealth saw min...
